Hemophilia without prophylaxis: Assessment of joint range of

Improvement in Joint Health Observed With Gene Therapy in Hemophilia A - Hematology Advisor

Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study

Manual and educational therapy in the treatment of hemophilic arthropathy of the elbow: a randomized pilot study, Orphanet Journal of Rare Diseases

Assessment of Joint Health and Outcome Measures in Hemophilia

Asymptomatic joint bleeding and joint health in hemophilia

Selecting Treatment Approaches in Hemophilia (Transcript)

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study - ScienceDirect

Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study - Matino - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM), Journal of Patient-Reported Outcomes

Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort - The Lancet Haematology

The bleeding phenotype in people with nonsevere hemophilia - ScienceDirect

Evaluating clinical joint status in boys with haemophilia receiving

Bleeding pattern, treatment, and outcome according to hemophilia type

Floor van Leeuwen on LinkedIn: The 4th paper of my PhD was published today in Haemophilia!🎉 We studied…